4
Changes in Ownership
TScan Therapeutics, Inc. Filed Acc 0000899243-21-049764
Chief Executive Officer acquired 48,670 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SOUTHWELL DAVID P Chief Executive Officer | 2021-12-23 | Option exercise | +48,670 | $1.97 | $95,880 | 146,569 | D: show line 1 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| SOUTHWELL DAVID P Chief Executive Officer | 2021-12-23 | Option exercise · Stock Option (Right to Buy) | −48,670 | 21,161 | D: show line 2 in the form |
Loading xslF345X03/doc4.xml…